ResearcherPhilipps University of MarburgNo recent work listed
Lars Plaßmeier
Matched on OpenAlex author ID A5091634700. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2013: 2 papers · 2014: 1 paper
Papers 3
- Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pan… Co-author DOI 10.1016/j.neo.2014.05.010↗
- Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancer. Co-author DOI 10.1007/s00423-013-1105-2↗
- Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Co-author DOI 10.1016/j.pan.2013.08.002↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Richard Friedemann Knoop · 3 shared papers, 2013–2014 · strength 0.12
- Paper Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a g… DOI 10.1016/j.neo.2014.05.010↗
- Paper Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered … DOI 10.1016/j.pan.2013.08.002↗
- Paper Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model o… DOI 10.1007/s00423-013-1105-2↗
- Detlef Klaus Bartsch · 3 shared papers, 2013–2014 · strength 0.12
- Paper Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a g… DOI 10.1016/j.neo.2014.05.010↗
- Paper Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered … DOI 10.1016/j.pan.2013.08.002↗
- Paper Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model o… DOI 10.1007/s00423-013-1105-2↗
- Volker Fendrich · 3 shared papers, 2013–2014 · strength 0.12
- Paper Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a g… DOI 10.1016/j.neo.2014.05.010↗
- Paper Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered … DOI 10.1016/j.pan.2013.08.002↗
- Paper Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model o… DOI 10.1007/s00423-013-1105-2↗
- Jens Waldmann · 3 shared papers, 2013–2014 · strength 0.12
- Paper Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a g… DOI 10.1016/j.neo.2014.05.010↗
- Paper Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered … DOI 10.1016/j.pan.2013.08.002↗
- Paper Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model o… DOI 10.1007/s00423-013-1105-2↗
- Matthias Lauth · 2 shared papers, 2013–2014 · strength 0.09
- Paper Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a g… DOI 10.1016/j.neo.2014.05.010↗
- Paper Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered … DOI 10.1016/j.pan.2013.08.002↗
- Malte Buchholz · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.